Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

NCT00527683 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: Vigabatrin
DRUG: Placebo
BEHAVIORAL: Group therapy

Sponsor

NYU Langone Health

Collaborators

[object Object]